{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:19:47Z","timestamp":1793812787950,"version":"4.6.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cervical cancer, a human papillomavirus (HPV) -driven malignancy with inherent viral antigenicity, serves as a key model in immuno-oncology. Yet, the variable efficacy of immune checkpoint inhibitors highlights a critical gap: the lack of preclinical models that accurately mirror the patient-specific tumor microenvironment (TME). Patient-derived organoids (PDOs) offer a transformative solution, preserving autologous tumor and immune components for personalized therapeutic testing. This study provides the first bibliometric analysis of this evolving field, mapping its knowledge structure from model development to immuno-oncological application. By analyzing 130 publications (1992-2025) from Web of Science, PubMed, and Scopus using VOSviewer and CiteSpace, we delineate a clear, three-stage evolution: from foundational HPV virology and culture techniques, through pivotal organoid methodology establishment (e.g., Burk RD, 2017), to the current translational phase. This progression is marked by citation bursts in TME modeling (e.g., Lohmussaar K, 2021) and the emergence of keywords like \u201cdrug screening\u201d and \u201cimmunotherapy\u201d. Research is dominated by the U.S., China, and European nations, published within an interdisciplinary core of oncology, immunology, and virology journals. Our analysis highlights the role of organoids as a crucial bridge linking basic virology to clinical immuno-oncology. However, standardization hurdles and suboptimal establishment rates for certain subtypes impede clinical translation. To realize the full potential of PDOs, future work must prioritize standardized immune-competent co-culture systems, integrate AI for high-content data analysis, and promote equitable global collaborations. Our analysis suggests the role of organoids as a crucial bridge linking basic virology to clinical immuno-oncology, highlighting that current advancements in tumor microenvironment modeling are establishing the necessary foundation for future immunotherapeutic applications.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1788725","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:31:17Z","timestamp":1787549477000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Building bridges to immunotherapy: a knowledge-mapping analysis of cervical cancer organoid research"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuanyuan","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoshi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Translational Medicine, the Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: a global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/frma.2024.1493944","article-title":"A bibliometric review of predictive modelling for cervical cancer risk","volume":"9","author":"Ngema","year":"2024","journal-title":"Front Res Metr Anal"},{"key":"B6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4258\/hir.2024.30.1.60","article-title":"Prediction of cervical cancer patients' survival period with machine learning techniques","volume":"30","author":"Chanudom","year":"2024","journal-title":"Healthc Inform Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5599\/admet.1513","article-title":"Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review","volume":"11","author":"Chunduri","year":"2022","journal-title":"ADMET DMPK"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.140","article-title":"Interrogating open issues in cancer precision medicine with patient-derived xenografts","volume":"17","author":"Byrne","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2174\/0113892029293113240427065916","article-title":"HPV16 genomes: in silico analysis of E6 and E7 oncoproteins in 20 South American variants","volume":"25","author":"de Paula Filho","year":"2024","journal-title":"Curr Genomics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/0113892029357275250721125929","article-title":"Precision medicine: transforming cancer research through targeted therapies","volume":"26","author":"Agrawal","year":"2025","journal-title":"Curr Genomics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stem.2021.03.012","article-title":"Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer","volume":"28","author":"L\u00f5hmussaar","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl3511","article-title":"Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids","volume":"10","author":"Song","year":"2024","journal-title":"Sci Adv"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010019","article-title":"Circulating tumor cell-derived pre-clinical models for personalized medicine","volume":"11","author":"Tellez-Gabriel","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29881","article-title":"Genetically engineered mouse model of HPV16 E6-E7 with vaginal-cervical intraepithelial neoplasia and decreased immunity","volume":"10","author":"Xiurong","year":"2024","journal-title":"Heliyon"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00366-w","article-title":"The application of CRISPR\/Cas9 system in cervical carcinogenesis","volume":"29","author":"Gao","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.04.015","article-title":"PIBF1 regulates multiple gene expression via impeding long-range chromatin interaction to drive the Malignant transformation of HPV16 integration epithelial cells","volume":"57","author":"Li","year":"2024","journal-title":"J Adv Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","article-title":"Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing","volume":"10","author":"Nanki","year":"2020","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1164985","article-title":"Review of possible mechanisms of radiotherapy resistance in cervical cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914609","article-title":"Exploring tumor-immune interactions in co-culture models of T cells and tumor organoids derived from patients","volume":"24","author":"Jeong","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e35","article-title":"Preclinical investigation of patient-derived cervical cancer organoids for precision medicine","volume":"34","author":"Seol","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103353","article-title":"Protocol for culturing patient-derived organoids of cervical cancer","volume":"5","author":"Wang","year":"2024","journal-title":"STAR Protoc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302340","article-title":"A promising new model: establishment of patient-derived organoid models covering HPV-related cervical pre-cancerous lesions and their cancers","volume":"11","author":"Hu","year":"2024","journal-title":"Adv Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-015-1645-z","article-title":"The bibliometric analysis of scholarly production: how great is the impact","volume":"105","author":"Ellegaard","year":"2015","journal-title":"Scientometrics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jdis-2017-0006","article-title":"Science mapping: a systematic review of the literature","volume":"2","author":"Chen","year":"2017","journal-title":"J Data Info Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32965","article-title":"Current trends and research topics regarding organoids: a bibliometric analysis of global research from 2000 to 2023","volume":"10","author":"Wan","year":"2024","journal-title":"Heliyon"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1433111","article-title":"Interpretation of the past, present, and future of organoid technology: an updated bibliometric analysis from 2009 to 2024","volume":"12","author":"Qu","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12964-024-01884-4","article-title":"Tumor-microenvironment-on-a-chip: the construction and application","volume":"22","author":"Xu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/1094428114562629","article-title":"Bibliometric methods in management and organization","volume":"18","author":"Zupic","year":"2015","journal-title":"Organizational Res Methods"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-017-2300-7","article-title":"Citation-based clustering of publications using CitNetExplorer and VOSviewer","volume":"111","author":"van Eck","year":"2017","journal-title":"Scientometrics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5530\/jscires.8.3.32","article-title":"Bibliometric analysis using Bibliometrix an R package","volume":"8","author":"Dervi","year":"2019","journal-title":"J Scientometr Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J Bus Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.09090626","article-title":"Bibliometric indicators: quality measurements of scientific publication","volume":"255","author":"Durieux","year":"2010","journal-title":"Radiology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/fut.22211","article-title":"Forty years of the Journal of Futures Markets: a bibliometric overview","volume":"41","author":"Baker","year":"2021","journal-title":"J Futures Markets"},{"key":"B40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40538-023-00428-1","article-title":"The visualized knowledge map and hot topic analysis of glomalin-related soil proteins in the carbon field based on Citespace","volume":"10","author":"Deng","year":"2023","journal-title":"Chem Biol Technol Agric"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-022-23283-3","article-title":"Bibliometric review of carbon neutrality with CiteSpace: evolution, trends, and framework","volume":"29","author":"Geng","year":"2022","journal-title":"Environ Sci pollut Res Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/w14081193","article-title":"Research development, current hotspots, and future directions of blue carbon: a bibliometric analysis","volume":"14","author":"Lai","year":"2022","journal-title":"Water"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat Protoc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/publications9010012","article-title":"Web of Science (WoS) and Scopus: the titans of bibliographic information in today\u2019s academic world","volume":"9","author":"Pranckut\u0117","year":"2021","journal-title":"Publications"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.90","article-title":"The history and meaning of the journal impact factor","volume":"295","author":"Garfield","year":"2006","journal-title":"JAMA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-015-1765-5","article-title":"The journal coverage of web of science and scopus: a comparative analysis","volume":"106","author":"Mongeon","year":"2016","journal-title":"Scientometrics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s11192-020-03690-4","article-title":"Google Scholar, Microsoft Academic, Scopus, Dimensions, Web of Science, and OpenCitations' COCI: a multidisciplinary comparison of coverage via citations","volume":"126","author":"Mart\u00edn-Mart\u00edn","year":"2021","journal-title":"Scientometrics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5539\/ass.v9n5p18","article-title":"A comparison between two main academic literature collections: web of science and scopus databases","volume":"9","author":"Chadegani","year":"2013","journal-title":"MPRA Paper"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.59717\/j.xinn-life.2024.100115","article-title":"When artificial intelligence (AI) meets organoids and organs-on-chips (OoCs): game-changer for drug discovery and development","volume":"3","author":"Zhou","year":"2025","journal-title":"Innovation Life"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1788725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:31:18Z","timestamp":1787549478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1788725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2026.1788725"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1788725","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1788725"}}